CCL5 and breast cancer: Given that the CCR5/CCL5 axis regulates DNA damage repair and breast cancer stem cell expansion [98], it remains to be tested whether RUNX dysregulation can elicit DNA damage in cancer stem cells through the transcriptional regulation of CCL5.